Hepatitis E virus and Bell's palsy.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
03 2022
Historique:
revised: 24 10 2021
received: 24 08 2021
accepted: 01 11 2021
pubmed: 9 11 2021
medline: 5 4 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

Acute hepatitis E virus (HEV) infections have been associated with various neurological disorders, including individual cases with Bell's palsy. Nonetheless, systematic studies in the latter are lacking. Therefore, this retrospective study systematically screened a cohort of patients with Bell's palsy for an acute HEV infection. Overall, 104 patients with Bell's palsy treated in our clinic between 2008 and 2018 were identified. Serum samples were analyzed for anti-HEV immunoglobulin (Ig)M and IgG antibodies by enzyme-linked immunosorbent assay. Additionally, serum samples were tested for HEV RNA by polymerase chain reaction in 92 of these 104 patients presenting within the first 7 days from symptom onset. A large group of 263 healthy individuals served as controls. None of the patients with Bell's palsy but two healthy controls (0.8%) had an acute HEV infection. Anti-HEV IgG seroprevalence indicating previous infection was unexpectedly high in patients with Bell's palsy (34%) and revealed an age-dependent increase. In this first systematic study, no cases of Bell's palsy in association with an acute HEV infection were identified. However, based on previous case descriptions, rare associations cannot be excluded. Therefore, large prospective multicenter studies will be necessary for conclusions that are more definitive.

Sections du résumé

BACKGROUND AND PURPOSE
Acute hepatitis E virus (HEV) infections have been associated with various neurological disorders, including individual cases with Bell's palsy. Nonetheless, systematic studies in the latter are lacking. Therefore, this retrospective study systematically screened a cohort of patients with Bell's palsy for an acute HEV infection.
METHODS
Overall, 104 patients with Bell's palsy treated in our clinic between 2008 and 2018 were identified. Serum samples were analyzed for anti-HEV immunoglobulin (Ig)M and IgG antibodies by enzyme-linked immunosorbent assay. Additionally, serum samples were tested for HEV RNA by polymerase chain reaction in 92 of these 104 patients presenting within the first 7 days from symptom onset. A large group of 263 healthy individuals served as controls.
RESULTS
None of the patients with Bell's palsy but two healthy controls (0.8%) had an acute HEV infection. Anti-HEV IgG seroprevalence indicating previous infection was unexpectedly high in patients with Bell's palsy (34%) and revealed an age-dependent increase.
CONCLUSIONS
In this first systematic study, no cases of Bell's palsy in association with an acute HEV infection were identified. However, based on previous case descriptions, rare associations cannot be excluded. Therefore, large prospective multicenter studies will be necessary for conclusions that are more definitive.

Identifiants

pubmed: 34748257
doi: 10.1111/ene.15175
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

820-825

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Zhang W, Xu L, Luo T, Wu F, Zhao B, Li X. The etiology of Bell’s palsy: a review. J Neurol. 2020;267:1896-1905. https://doi.org/10.1007/s00415-019-09282-4
Baugh RF, Basura GJ, Ishii LE, et al. Clinical practice guideline: Bell’s palsy. Otolaryngol Neck Surg. 2013;149:S1-S27. https://doi.org/10.1177/0194599813505967
Eviston TJ, Croxson GR, Kennedy PGE, Hadlock T, Krishnan AV. Bell’s palsy: aetiology, clinical features and multidisciplinary care. J Neurol Neurosurg Psychiatry. 2015;86:1356-1361. https://doi.org/10.1136/jnnp-2014-309563
Glass GE, Tzafetta K. Bell’s palsy: a summary of current evidence and referral algorithm. Fam Pract. 2014;31:631-642. https://doi.org/10.1093/fampra/cmu058
Henkel K, Lange P, Eiffert H, Nau R, Spreer A. Infections in the differential diagnosis of Bell’s palsy: a plea for performing CSF analysis. Infection. 2017;45:147-155. https://doi.org/10.1007/s15010-016-0933-8.
Jha AK, Nijhawan S, Nepalia S, Suchismita A. Association of Bell’s palsy with hepatitis E virus infection: a rare entity. J Clin Exp Hepatol. 2012;2:88-90. https://doi.org/10.1016/S0973-6883(12)60082-6
Yazaki Y, Sugawara K, Honda M, et al. Characteristics of 20 patients with autochthonous acute hepatitis E in Hokkaido, Japan: first report of bilateral facial palsy following the infection with genotype 4 Hepatitis E Virus. Tohoku J Exp Med. 2015;236:263-271. https://doi.org/10.1620/tjem.236.263
Nakamura M, Kusumoto K, Ochiai T, et al. Two cases of acute hepatitis E infected with descendant strains of hepatitis E virus genotype 3 strain isolated from swine herd in Miyazaki Prefecture 12 years ago - one case had acute facial paralysis. Nihon Shokakibyo Gakkai Zasshi. 2015;112:1533-1541. https://doi.org/10.11405/nisshoshi.112.1533
Belbézier A, Deroux A, Sarrot-Reynauld F, et al. Screening of hepatitis E in patients presenting for acute neurological disorders. J Infect Public Health. 2020;13:1047-1050. https://doi.org/10.1016/j.jiph.2019.12.012
Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell’s palsy. J Assoc Physicians India. 2006;54:418.
McLean BN, Gulliver J, Dalton HR. Hepatitis E virus and neurological disorders. Pract Neurol. 2017;17:282-288. https://doi.org/10.1136/practneurol-2016-001588
Fousekis FS, Mitselos IV, Christodoulou DK. Extrahepatic manifestations of hepatitis E virus: an overview. Clin Mol Hepatol. 2020;26:16-23. https://doi.org/10.3350/cmh.2019.0082
Faber M, Willrich N, Schemmerer M, et al. Hepatitis E virus seroprevalence, seroincidence and seroreversion in the German adult population. J Viral Hepat. 2018;25:752-758. https://doi.org/10.1111/jvh.12868
Fritz-Weltin M, Isenmann N, Frommherz E, et al. Acute CNS infections - expanding the spectrum of neurological manifestations of hepatitis E virus? J Neurol Sci. 2021;423:117387. https://doi.org/10.1016/j.jns.2021.117387
Fritz-Weltin M, Frommherz E, Isenmann N, et al. Hepatitis E virus as a trigger for Guillain-Barré syndrome. BMC Neurol. 2021;21:304. https://doi.org/10.1186/s12883-021-02334-1
Abravanel F, Pique J, Couturier E, et al. Acute hepatitis E in French patients and neurological manifestations. J Infect. 2018;77:220-226. https://doi.org/10.1016/j.jinf.2018.06.007
Dalton HR, van Eijk JJJ, Cintas P, et al. Hepatitis E virus infection and acute non-traumatic neurological injury: a prospective multicentre study. J Hepatol. 2017;67:925-932. https://doi.org/10.1016/j.jhep.2017.07.010
Van Eijk JJJ, Madden RG, Van Der Eijk AA, et al. Neuralgic amyotrophy and hepatitis E virus infection. Neurology. 2014;82:498-503. https://doi.org/10.1212/WNL.0000000000000112
Fritz M, Berger B, Schemmerer M, et al. Pathological cerebrospinal fluid findings in patients with neuralgic amyotrophy and acute hepatitis e virus infection. J Infect Dis. 2018;217:1897-1901. https://doi.org/10.1093/infdis/jiy128
Ripellino P, Norton B, van Eijk J, Dalton HR. Non-traumatic neurological injury and hepatitis E infection. Expert Rev Anti Infect Ther. 2018;16:255-257. https://doi.org/10.1080/14787210.2018.1446827
Webb GW, Dalton HR. Hepatitis E: an underestimated emerging threat. Ther Adv Infect Dis. 2019;6:204993611983716. https://doi.org/10.1177/2049936119837162
Rösler KM, Magistris MR, Glocker FX, Kohler A, Deuschl G, Hess CW. Electrophysiological characteristics of lesions in facial palsies of different etiologies. A study using electrical and magnetic stimulation techniques. Electroencephalogr Clin Neurophysiol Electromyogr. 1995;97:355-368. https://doi.org/10.1016/0924-980X(95)00134-7
Zhou X, Huang F, Xu L, et al. Hepatitis E virus infects neurons and brains. J Infect Dis. 2017;215:1197-1206. https://doi.org/10.1093/infdis/jix079
Shi R, Soomro MH, She R, et al. Evidence of Hepatitis E virus breaking through the blood-brain barrier and replicating in the central nervous system. J Viral Hepat. 2016;23:930-939. https://doi.org/10.1111/jvh.12557
Drave SA, Debing Y, Walter S, et al. Extra-hepatic replication and infection of hepatitis E virus in neuronal-derived cells. J Viral Hepat. 2016;23:512-521. https://doi.org/10.1111/jvh.12515
Troussière AC, Sudaveschi V, Collardelle P, Marque Julliet S, Servan J, Pico F. Guillain-Barré syndrome due to hepatitis E. Rev Neurol (Paris). 2018;174:72-74. https://doi.org/10.1016/j.neurol.2017.06.018
Comont T, Bonnet D, Sigur N, et al. HépatiteE aiguë associée à un syndrome de Guillain-Barré chez un patient immunocompétent. Rev Med Interne. 2014;35:333-336. https://doi.org/10.1016/j.revmed.2013.05.005
Kamar N, Bendall R, Legrand-Abravanel F, et al. Hepatitis E. Lancet. 2012;379(9835):2477-2488. https://doi.org/10.1016/S0140-6736(11)61849-7
Dalton HR, Kamar N, Baylis SA, Moradpour D, Wedemeyer H, Negro F. EASL Clinical Practice Guidelines on hepatitis E virus infection. J Hepatol. 2018;68:1256-1271. https://doi.org/10.1016/j.jhep.2018.03.005
Huang S, Zhang X, Jiang H, et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One. 2010;5:e13560. https://doi.org/10.1371/journal.pone.0013560

Auteurs

Miriam Fritz-Weltin (M)

Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Lisa Niedermeier (L)

Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Estelle Frommherz (E)

Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nora Isenmann (N)

Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Benedikt Csernalabics (B)

Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Tobias Boettler (T)

Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Christoph Neumann-Haefelin (C)

Department of Medicine II, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Dominique Endres (D)

Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Marcus Panning (M)

Institute of Virology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Benjamin Berger (B)

Clinic of Neurology and Neurophysiology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH